Replies to post #212949 on Biotech Values

[DewDiligence]

RDUS—$345M* convertible debt has conversion price of $48.81—a 33% premium to yesterday’s close for the common stock:

https://finance.yahoo.com/news/radius-health-announces-pricing-300-031656794.html

*Assuming exercise of underwriter’s option.